Brief: Moonlake Immunotherapeutics Reports Q3 2024 Financial Results And Provides A Business Update
07/11/2024 12:20
Nov 7 (Reuters) - MoonLake Immunotherapeutics MLTX.O :
* MOONLAKE IMMUNOTHERAPEUTICS REPORTS THIRD QUARTER 2024
FINANCIAL
RESULTS AND PROVIDES A BUSINESS UPDATE
* MOONLAKE IMMUNOTHERAPEUTICS: CASH RUNWAY TO END OF 2026
Source text: ID:nGNXbgslb5
Further company coverage: MLTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MoonLake Immunotherapeutics
See all newsMoonLake jumps as AbbVie's weak skin drug data eases competition fears
Brief: Moonlake Immunotherapeutics Files For Mixed Shelf Offering, Size Not Disclosed
MoonLake Immunotherapeutics reports results for the quarter ended June 30 - Earnings Summary
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial (updated)
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial